One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
How to Use Fluorescence Calibration SlidesApril 10, 2024As a key tool in biomedical research, the fluorescence characteristics and stability of fluorescence calibration slides are directly related to the accuracy and reliability of experiments. This paper ...view
Diagnostic Methods for Brain CancerApril 4, 2023Brain cancer is a very difficult-to-treat neurological disease, also known as a brain tumor. Many patients ask the question, can brain cancer be cured? The earlier brain cancer is treated, the better....view